Fidelity Select Biotech Portfolio is openend fund incorporated in the USA. The purpose of the IMF is capital appreciation. Funds are typically invests at least 85% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of a variety of biotech products, services, and processes.
In the page of the official website we can find:
1yr, 3yrs, 5yrs, 10yrs Year/Life values are Average Annual Total returns. Life of Fund figures are reported as of the inception date of the fund or share class. YTD (Daily) value is cumulative total returns from either the beginning of the biocalendar year or the inception of the fund, if the fund incepted after the beginning of the current year.
It is a fact-high level of investor funds can be used to help evaluate investment options, including the amount of the net assets of the fund, the ratio of the cost, and the current net asset value of the fund.
Hypothetical Growth of $10,000
This point data, usually displayed as a graph, showing how the value of a hypothetical $ 10,000 investment in the fund will change from time to time. It can also be used to compare the historical performance of funds against the benchmark or average Morningstar category. This measurement does not include the cost, even assuming reinvestment of all dividends and capital gain distributions.
Top 10 Holdings
10 holdings in which these funds have the biggest investment, on the date shown. For Fidelity funds, this information is updated every three months, with a lag of one month. For other funds, is updated based on the information disclosure policies of each company funds.
Similar Fund Picks from Fidelity
Why Choose Picks From Fidelity Funds?
- There are no transaction fees
- 3-year performance history tracked
- Fund offers three years of highest risk-adjusted returns in Morningstar category
investment profile are taken into account, including the main feature and the minimum investment
and the bottom left corner you can find:
Looking for capital appreciation.
Invests primarily in companies engaged in the research, development, manufacture, and distribution of various biotechnological products, services and processes and companies that benefit significantly from advances in science and technology in the field of biotechnology. Usually investing at least 80% of assets in securities of companies principally engaged in such activities. Usually invests primarily in common stocks.
the stock market, especially in overseas markets, the situation is not stable and can decline significantly in response to adverse issuer, regulatory, political, market or economic developments. Foreign securities are subject to interest rates, currency exchange rates, political and economic risks. focus funds can be more stable because of their narrow concentration in a specific industry. The biotechnology industry can be significantly affected by patent considerations, intense competition, rapid technological change and worn, and government regulations. The fund may have a number of additional volatility as they may invest most of the assets that exist on the effects of a small number of individual issuers. additional disclosures
This description is intended to provide a brief overview of the mutual funds. Read the fund prospectus for more detailed information about the fund.
Quarter-End Average Annual Total Returns
The Quarter-end total average annual return is the rate of return on a quarterly basis which, if achieved annually, will produce the same cumulative total return if the performance has been constant over the entire period. The total average annual yield smooth out variations in performance; they are not the same as actual results year after year.